SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-086117
Filing Date
2022-08-04
Accepted
2022-08-04 16:06:07
Documents
2
Period of Report
2022-07-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2222420-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2222420-1_4seq1.xml 4 4150
2 EXHIBIT 24 tm2222420d1_ex24.htm EX-24 5879
  Complete submission text file 0001104659-22-086117.txt   11565
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYTODYN INC. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Kelly Scott A. (Reporting) CIK: 0001703394 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 221136475